Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility are currrently unavailable.

Steven Kyle Grinspoon, M.D.

Co-Author

This page shows the publications co-authored by Steven Grinspoon and Kathleen Fitch.
Connection Strength

12.444
  1. Subclinical myocyte injury, fibrosis and strain in relationship to coronary plaque in asymptomatic HIV-infected individuals. AIDS. 2016 09 10; 30(14):2205-14.
    View in: PubMed
    Score: 0.696
  2. Noncalcified coronary atherosclerotic plaque and immune activation in HIV-infected women. J Infect Dis. 2013 Dec 01; 208(11):1737-46.
    View in: PubMed
    Score: 0.566
  3. Effects of aging and smoking on carotid intima-media thickness in HIV-infection. AIDS. 2013 Jan 02; 27(1):49-57.
    View in: PubMed
    Score: 0.539
  4. Effects of lifestyle modification and metformin on atherosclerotic indices among HIV-infected patients with the metabolic syndrome. AIDS. 2012 Mar 13; 26(5):587-97.
    View in: PubMed
    Score: 0.509
  5. Nutritional and metabolic correlates of cardiovascular and bone disease in HIV-infected patients. Am J Clin Nutr. 2011 Dec; 94(6):1721S-1728S.
    View in: PubMed
    Score: 0.498
  6. Therapy: HIV-associated dyslipidemia: the heart positive study. Nat Rev Endocrinol. 2011 Jun 21; 7(8):443-4.
    View in: PubMed
    Score: 0.484
  7. Associations of cardiovascular risk factors with two surrogate markers of subclinical atherosclerosis: endothelial function and carotid intima media thickness. Atherosclerosis. 2011 Aug; 217(2):437-40.
    View in: PubMed
    Score: 0.478
  8. Relationship between neck circumference and cardiometabolic parameters in HIV-infected and non-HIV-infected adults. Diabetes Care. 2011 Apr; 34(4):1026-31.
    View in: PubMed
    Score: 0.474
  9. Increased coronary artery calcium score and noncalcified plaque among HIV-infected men: relationship to metabolic syndrome and cardiac risk parameters. J Acquir Immune Defic Syndr. 2010 Dec; 55(4):495-9.
    View in: PubMed
    Score: 0.466
  10. Decreased respiratory quotient in relation to resting energy expenditure in HIV-infected and noninfected subjects. Metabolism. 2009 May; 58(5):608-15.
    View in: PubMed
    Score: 0.418
  11. Effects of a lifestyle modification program in HIV-infected patients with the metabolic syndrome. AIDS. 2006 Sep 11; 20(14):1843-50.
    View in: PubMed
    Score: 0.348
  12. Altered pattern of circulating miRNAs in HIV lipodystrophy perturbs key adipose differentiation and inflammation pathways. JCI Insight. 2021 Sep 22; 6(18).
    View in: PubMed
    Score: 0.246
  13. Corrigendum to: Patterns of Antiretroviral Therapy Use and Immunologic Profiles at Enrollment in the REPRIEVE Trial. J Infect Dis. 2021 02 03; 223(2):352.
    View in: PubMed
    Score: 0.236
  14. Differential Plasma Protein Regulation and Statin Effects in Human Immunodeficiency Virus (HIV)-Infected and Non-HIV-Infected Patients Utilizing a Proteomics Approach. J Infect Dis. 2020 08 17; 222(6):929-939.
    View in: PubMed
    Score: 0.228
  15. Successful recruitment of a multi-site international randomized placebo-controlled trial in people with HIV with attention to diversity of race and ethnicity: critical role of central coordination. HIV Res Clin Pract. 2020 02; 21(1):11-23.
    View in: PubMed
    Score: 0.222
  16. Brief Report: Adipogenic Expression of Brown Fat Genes in HIV and HIV-Related Parameters. J Acquir Immune Defic Syndr. 2019 12 15; 82(5):491-495.
    View in: PubMed
    Score: 0.218
  17. Rationale and design of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE). Am Heart J. 2019 06; 212:23-35.
    View in: PubMed
    Score: 0.206
  18. Comparison of visceral fat measurement by dual-energy X-ray absorptiometry to computed tomography in HIV and non-HIV. Nutr Diabetes. 2019 02 25; 9(1):6.
    View in: PubMed
    Score: 0.206
  19. Mild renal impairment is associated with calcified plaque parameters assessed by computed tomography angiography in people living with HIV. AIDS. 2019 02 01; 33(2):219-227.
    View in: PubMed
    Score: 0.205
  20. Relationship of visceral and subcutaneous adipose depots to markers of arterial injury and inflammation among individuals with HIV. AIDS. 2019 02 01; 33(2):229-236.
    View in: PubMed
    Score: 0.205
  21. Diet Quality Is Low and Differs by Sex in People with HIV. J Nutr. 2019 01 01; 149(1):78-87.
    View in: PubMed
    Score: 0.204
  22. Significant Association of Aldosterone and Liver Fat Among HIV-Infected Individuals With Metabolic Dysregulation. J Endocr Soc. 2018 Oct 01; 2(10):1147-1157.
    View in: PubMed
    Score: 0.199
  23. Assessing statin effects on cardiovascular pathways in HIV using a novel proteomics approach: Analysis of data from INTREPID, a randomized controlled trial. EBioMedicine. 2018 Sep; 35:58-66.
    View in: PubMed
    Score: 0.199
  24. Randomized, Placebo-Controlled Trial to Evaluate Effects of Eplerenone on Metabolic and Inflammatory Indices in HIV. J Clin Endocrinol Metab. 2018 06 01; 103(6):2376-2384.
    View in: PubMed
    Score: 0.196
  25. Insulin-like growth factor 1 inversely relates to monocyte/macrophage activation markers in HIV. AIDS. 2018 04 24; 32(7):927-932.
    View in: PubMed
    Score: 0.195
  26. Differential relationships of hepatic and epicardial fat to body composition in HIV. Physiol Rep. 2017 Oct; 5(19).
    View in: PubMed
    Score: 0.188
  27. Proprotein Convertase Subtilisin/Kexin 9 Levels in Relation to Systemic Immune Activation and Subclinical Coronary Plaque in HIV. Open Forum Infect Dis. 2017; 4(4):ofx227.
    View in: PubMed
    Score: 0.188
  28. Aspartame Intake Relates to Coronary Plaque Burden and Inflammatory Indices in Human Immunodeficiency Virus. Open Forum Infect Dis. 2017; 4(2):ofx083.
    View in: PubMed
    Score: 0.182
  29. Effects of pitavastatin and pravastatin on markers of immune activation and arterial inflammation in HIV. AIDS. 2017 03 27; 31(6):797-806.
    View in: PubMed
    Score: 0.181
  30. Effects of Sodium Restriction on Activation of the Renin-Angiotensin-Aldosterone System and Immune Indices During HIV Infection. J Infect Dis. 2016 Nov 01; 214(9):1336-1340.
    View in: PubMed
    Score: 0.173
  31. Dysfunctional Subcutaneous Fat With Reduced Dicer and Brown Adipose Tissue Gene Expression in HIV-Infected Patients. J Clin Endocrinol Metab. 2016 Mar; 101(3):1225-34.
    View in: PubMed
    Score: 0.166
  32. HIV-Related Cardiovascular Disease, Statins, and the REPRIEVE Trial. Top Antivir Med. 2015 Oct-Nov; 23(4):146-9.
    View in: PubMed
    Score: 0.163
  33. RAAS Activation Is Associated With Visceral Adiposity and Insulin Resistance Among HIV-infected Patients. J Clin Endocrinol Metab. 2015 Aug; 100(8):2873-82.
    View in: PubMed
    Score: 0.160
  34. Plaque burden in HIV-infected patients is associated with serum intestinal microbiota-generated trimethylamine. AIDS. 2015 Feb 20; 29(4):443-52.
    View in: PubMed
    Score: 0.156
  35. Effects of statin therapy on coronary artery plaque volume and high-risk plaque morphology in HIV-infected patients with subclinical atherosclerosis: a randomised, double-blind, placebo-controlled trial. Lancet HIV. 2015 Feb; 2(2):e52-63.
    View in: PubMed
    Score: 0.155
  36. Soluble CD163 is associated with shortened telomere length in HIV-infected patients. J Acquir Immune Defic Syndr. 2014 Dec 01; 67(4):414-418.
    View in: PubMed
    Score: 0.154
  37. Effects of lifestyle modification and metformin on irisin and FGF21 among HIV-infected subjects with the metabolic syndrome. Clin Endocrinol (Oxf). 2015 May; 82(5):678-85.
    View in: PubMed
    Score: 0.152
  38. 2013 American College of Cardiology/American Heart Association and 2004 Adult Treatment Panel III cholesterol guidelines applied to HIV-infected patients with/without subclinical high-risk coronary plaque. AIDS. 2014 Sep 10; 28(14):2061-70.
    View in: PubMed
    Score: 0.151
  39. Increased coronary atherosclerosis and immune activation in HIV-1 elite controllers. AIDS. 2012 Nov 28; 26(18):2409-12.
    View in: PubMed
    Score: 0.134
  40. Increased FDG uptake in association with reduced extremity fat in HIV patients. Antivir Ther. 2013; 18(2):243-8.
    View in: PubMed
    Score: 0.132
  41. Deiodinase 2 expression is increased in dorsocervical fat of patients with HIV-associated lipohypertrophy syndrome. J Clin Endocrinol Metab. 2012 Apr; 97(4):E602-7.
    View in: PubMed
    Score: 0.126
  42. Relation of body composition to body mass index in HIV-infected patients with metabolic abnormalities. J Acquir Immune Defic Syndr. 2008 Feb 01; 47(2):174-84.
    View in: PubMed
    Score: 0.096
  43. Dietary fat intake and relationship to serum lipid levels in HIV-infected patients with metabolic abnormalities in the HAART era. AIDS. 2007 Jul 31; 21(12):1591-600.
    View in: PubMed
    Score: 0.092
  44. Effects of a nucleoside reverse transcriptase inhibitor, stavudine, on glucose disposal and mitochondrial function in muscle of healthy adults. Am J Physiol Endocrinol Metab. 2007 Jun; 292(6):E1666-73.
    View in: PubMed
    Score: 0.089
  45. Carotid intimal medial thickness in human immunodeficiency virus-infected women: effects of protease inhibitor use, cardiac risk factors, and the metabolic syndrome. J Clin Endocrinol Metab. 2006 Dec; 91(12):4916-24.
    View in: PubMed
    Score: 0.087
  46. Absence of polycystic ovary syndrome features in human immunodeficiency virus-infected women despite significant hyperinsulinemia and truncal adiposity. J Clin Endocrinol Metab. 2005 Oct; 90(10):5596-604.
    View in: PubMed
    Score: 0.081
  47. Sustainable food systems and nutrition in the 21st century: A report from the 22nd annual harvard nutrition obesity symposium. Am J Clin Nutr. 2021 Sep 15.
    View in: PubMed
    Score: 0.062
  48. Cardiovascular Risk and Health Among People With HIV Eligible for Primary Prevention: Insights From the REPRIEVE Trial. Clin Infect Dis. 2021 Jun 16.
    View in: PubMed
    Score: 0.060
  49. Assessment of Coronary Artery Disease With Computed Tomography Angiography and Inflammatory and Immune Activation Biomarkers Among Adults With HIV Eligible for Primary Cardiovascular Prevention. JAMA Netw Open. 2021 Jun 01; 4(6):e2114923.
    View in: PubMed
    Score: 0.060
  50. Myocardial Steatosis Among Antiretroviral Therapy-Treated People With Human Immunodeficiency Virus Participating in the REPRIEVE Trial. J Infect Dis. 2020 07 09; 222(Suppl 1):S63-S69.
    View in: PubMed
    Score: 0.057
  51. Correlates and Timing of Reproductive Aging Transitions in a Global Cohort of Midlife Women With Human Immunodeficiency Virus: Insights From the REPRIEVE Trial. J Infect Dis. 2020 07 09; 222(Suppl 1):S20-S30.
    View in: PubMed
    Score: 0.057
  52. Characteristics of REPRIEVE Trial Participants Identifying Across the Transgender Spectrum. J Infect Dis. 2020 07 09; 222(Suppl 1):S31-S40.
    View in: PubMed
    Score: 0.057
  53. Patterns of Antiretroviral Therapy Use and Immunologic Profiles at Enrollment in the REPRIEVE Trial. J Infect Dis. 2020 07 09; 222(Suppl 1):S8-S19.
    View in: PubMed
    Score: 0.057
  54. Physical Function Impairment and Frailty in Middle-Aged People Living With Human Immunodeficiency Virus in the REPRIEVE Trial Ancillary Study PREPARE. J Infect Dis. 2020 07 09; 222(Suppl 1):S52-S62.
    View in: PubMed
    Score: 0.057
  55. An Evaluation of Baseline Kidney Function in the REPRIEVE Trial of Pitavastatin in Human Immunodeficiency Virus. J Infect Dis. 2020 07 09; 222(Suppl 1):S41-S51.
    View in: PubMed
    Score: 0.057
  56. Measures of Adipose Tissue Redistribution and Atherosclerotic Coronary Plaque in HIV. Obesity (Silver Spring). 2020 04; 28(4):749-755.
    View in: PubMed
    Score: 0.055
  57. Serum Lipocalin 2 (Neutrophil Gelatinase-Associated Lipocalin) in Relation to Biomarkers of Inflammation and Cardiac Stretch During Activation of the Renin-Angiotensin-Aldosterone System in Human Immunodeficiency Virus. J Infect Dis. 2019 09 26; 220(9):1420-1424.
    View in: PubMed
    Score: 0.054
  58. Rationale and design of the Mechanistic Substudy of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE): Effects of pitavastatin on coronary artery disease and inflammatory biomarkers. Am Heart J. 2019 06; 212:1-12.
    View in: PubMed
    Score: 0.052
  59. Brief Report: Statin Effects on Myocardial Fibrosis Markers in People Living With HIV. J Acquir Immune Defic Syndr. 2018 05 01; 78(1):105-110.
    View in: PubMed
    Score: 0.049
  60. Excessive Adiposity and Metabolic Dysfunction Relate to Reduced Natriuretic Peptide During RAAS Activation in HIV. J Clin Endocrinol Metab. 2018 04 01; 103(4):1558-1565.
    View in: PubMed
    Score: 0.048
  61. Acute hyperinsulinemia effects on systemic markers of immune activation in HIV. AIDS. 2017 07 31; 31(12):1771-1773.
    View in: PubMed
    Score: 0.046
  62. Follow YOUR Heart: development of an evidence-based campaign empowering older women with HIV to participate in a large-scale cardiovascular disease prevention trial. HIV Clin Trials. 2017 03; 18(2):83-91.
    View in: PubMed
    Score: 0.045
  63. A multiplexed targeted assay for high-throughput quantitative analysis of serum methylamines by ultra performance liquid chromatography coupled to high resolution mass spectrometry. Arch Biochem Biophys. 2016 05 01; 597:12-20.
    View in: PubMed
    Score: 0.042
  64. Serum oxidized low-density lipoprotein decreases in response to statin therapy and relates independently to reductions in coronary plaque in patients with HIV. AIDS. 2016 Feb 20; 30(4):583-90.
    View in: PubMed
    Score: 0.042
  65. Reduced ovarian reserve relates to monocyte activation and subclinical coronary atherosclerotic plaque in women with HIV. AIDS. 2016 Jan 28; 30(3):383-93.
    View in: PubMed
    Score: 0.042
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.